Tracking Cathie Wood: Aggressively buying Google, adding to positions in Alibaba and Meta, while continuously reducing exposure to the genomic sequencing healthcare sector

On Wednesday, June 3, 2026, U.S. Eastern Time, the three major U.S. stock indices pulled back from record highs amid heightened tensions in the Middle East and inflation concerns triggered by rising crude oil prices.

Amid this market environment, Cathie Wood's investment 'sector rotation' continues: on the buying side, she aggressively purchased AI giants under short-term pressure due to massive equity financing, $Alphabet-C (GOOG.US)$ ; on the selling side, she continued offloading positions in the 'gene sequencing and synthetic biology' sector.

Buying Direction: Returning to internet giants, increasing exposure to AI and cloud computing

She bought over 267,600 shares of Google on a dip.This was the largest purchase of the day; Cathie Wood simultaneously acquired both Class A shares $Alphabet-A (GOOGL.US)$ and Class C shares $Alphabet-C (GOOG.US)$ of Google, each amounting to 133,800 shares. In early June, Google announced an equity financing plan worth up to $84.75 billion (initially $80 billion). This rare, massive capital raise immediately sparked market concerns over equity dilution, causing a short-term drop in its share price. Cathie Wood took advantage of the dip, reflecting her continued confidence in Google’s prospects in 'AI infrastructure + diverse application scenarios.'

Buy $Alibaba (BABA.US)$30,300 shares.With the release of its full fiscal year 2026 results in mid-May 2026, Alibaba has demonstrated strong momentum in its 'Alibaba Cloud AI large model open-source ecosystem,' and its core e-commerce segment’s profit margin is gradually stabilizing. Although the market remains concerned about short-term profit declines caused by heavy subsidies and infrastructure investments, Cathie Wood places greater emphasis on the explosive growth potential of its 'AI + Cloud' business.

Steady position increase $Meta Platforms (META.US)$5,608 shares.Meta continues to solidify its dominance in social and digital advertising by leveraging its powerful open-source large models (Llama ecosystem) and deeply integrating AI into its core ad algorithms. This move represents a timely and prudent position increase, further enhancing portfolio certainty.

Selling direction: Major retreat from the genomics sector, continued divestment of legacy hardware

Continued selling of genomics sequencing and synthetic biology positions: reduced stake in the single-cell sequencing leader $10x Genomics (TXG.US)$218,400 shares, genetic diagnostics $Veracyte (VCYT.US)$112,100 shares, synthetic biology $Twist Bioscience (TWST.US)$96,100 shares.

These three companies were once ARK’s favorites in the healthcare innovation space. However, amid the current AI boom, biotech firms with long R&D cycles and slower commercialization face significant valuation pressure. Cathie Wood decisively chose to exit these positions, reallocating capital from these long-duration assets to targets with stronger near-term monetization potential.

Reduce holdings $Baidu (BIDU.US)$106,500 shares.According to Baidu's newly released Q1 2026 financial report, revenue from its core AI-driven businesses reached RMB 13.6 billion, a 49% year-over-year increase, accounting for over 50% of total revenue for the first time—marking Baidu's official transformation into an AI company. Despite the impressive AI growth, total Q1 revenue declined 2% quarter-over-quarter to RMB 32.1 billion due to intensifying competition in the broader advertising market, raising investor concerns.

Continuing the trend of taking profits from legacy hardware and test equipment: reduced holdings of $Advanced Micro Devices (AMD.US)$74,800 shares, and reduced holdings of $Teradyne (TER.US)$46,700 shares.These two transactions fully align with the portfolio adjustment logic seen in recent days. Amid the frenetic iteration of AI computing chips, AMD—still playing catch-up—and TER, a semiconductor test equipment vendor positioned in the later stages of the semiconductor cycle, lack exponential growth potential. Cathie Wood continues to remove them from the portfolio, reallocating capital to enhance overall allocation efficiency.

Futubull [Opportunities page] Now featuring the ability to track portfolios of renowned investors! Choose from multiple celebrity holdings, follow the investment strategies of top players with one click, accurately target high-quality stocks, and invest with greater confidence!

526K Views